自己免疫疾患治療薬の世界市場 2023-2027

当レポートでは自己免疫疾患治療薬の市場規模は、2022年から2027年の間に293億1,450万米ドルの増加が見込まれ、予測期間中に6.39%のCAGRで成長すると予測しています。

当レポートでは、自己免疫疾患治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析を行っています。

現在の市場動向と促進要因、市場環境全体に関する最新の分析を提供しています。市場は、強力な研究開発パイプライン、生物製剤の標的治療メカニズム、手頃な価格のバイオシミラーの導入によって牽引されています。

本調査では、自己免疫疾患治療薬のコスト削減が、今後数年間の自己免疫疾患治療薬市場の成長を促進する主要な理由の1つであると位置付けています。また、TNFα阻害剤による市場の支配と新薬の開発・承認が、市場の大きな需要につながると考えています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 世界の自己免疫薬市場2017～2021年
• 治療領域セグメント分析2017-2021
• 流通チャネルセグメント分析2017-2021
• 地域セグメント分析2017-2021
• 国セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 治療分野別の市場セグメンテーション

• マーケット・セグメント
• 治療領域別比較
• 関節リウマチ - 市場規模と予測 2022-2027
• 多発性硬化症 - 市場規模と予測 2022-2027
• 乾癬 - 市場規模と予測 2022-2027
• 炎症性腸疾患 - 市場規模と予測 2022-2027
• その他 - 市場規模と予測 2022-2027
• 治療領域別の市場機会

第7章 流通チャネル別市場セグメンテーション

• マーケット・セグメント
• 流通チャネル別比較
• 病院 - 市場規模と予測 2022-2027
• 薬局 - 市場規模と予測 2022-2027
• ドラッグストア/小売薬局 - 市場規模と予測 2022-2027
• オンライン - 市場規模と予測 2022-2027
• 流通チャネル別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• カナダ - 市場規模と予測 2022-2027
• 中国 - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• 地域別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca Plc
• Bristol Myers Squibb Co.
• Cardinal Health Inc.
• Delphis Pharmaceutical India
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Hikma Pharmaceuticals Plc
• Johnson and Johnson
• Parvus Therapeutics Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy Area
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global autoimmune drugs market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Therapy Area - Market share 2022-2027 (%)
• Exhibits31: Data Table on Therapy Area - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Therapy Area
• Exhibits33: Data Table on Comparison by Therapy Area
• Exhibits34: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
• Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits54: Market opportunity by Therapy Area ($ million)
• Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits57: Chart on Comparison by Distribution Channel
• Exhibits58: Data Table on Comparison by Distribution Channel
• Exhibits59: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
• Exhibits60: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Chart on Hospital - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on Pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on Pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on Pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on Pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Online - Year-over-year growth 2022-2027 (%)
• Exhibits75: Market opportunity by Distribution Channel ($ million)
• Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits77: Chart on Market share by geography 2022-2027 (%)
• Exhibits78: Data Table on Market share by geography 2022-2027 (%)
• Exhibits79: Chart on Geographic comparison
• Exhibits80: Data Table on Geographic comparison
• Exhibits81: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits83: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits87: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits91: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits98: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits99: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits107: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits109: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits110: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits111: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits112: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits113: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits114: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits115: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits116: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits117: Market opportunity by geography ($ million)
• Exhibits118: Impact of drivers and challenges in 2022 and 2027
• Exhibits119: Overview on Criticality of inputs and Factors of differentiation
• Exhibits120: Overview on factors of disruption
• Exhibits121: Impact of key risks on business
• Exhibits122: Vendors covered
• Exhibits123: Matrix on vendor position and classification
• Exhibits124: AbbVie Inc. - Overview
• Exhibits125: AbbVie Inc. - Product / Service
• Exhibits126: AbbVie Inc. - Key news
• Exhibits127: AbbVie Inc. - Key offerings
• Exhibits128: Amgen Inc. - Overview
• Exhibits129: Amgen Inc. - Product / Service
• Exhibits130: Amgen Inc. - Key offerings
• Exhibits131: AstraZeneca Plc - Overview
• Exhibits132: AstraZeneca Plc - Product / Service
• Exhibits133: AstraZeneca Plc - Key news
• Exhibits134: AstraZeneca Plc - Key offerings
• Exhibits135: Bristol Myers Squibb Co. - Overview
• Exhibits136: Bristol Myers Squibb Co. - Product / Service
• Exhibits137: Bristol Myers Squibb Co. - Key news
• Exhibits138: Bristol Myers Squibb Co. - Key offerings
• Exhibits139: Cardinal Health Inc. - Overview
• Exhibits140: Cardinal Health Inc. - Business segments
• Exhibits141: Cardinal Health Inc. - Key news
• Exhibits142: Cardinal Health Inc. - Key offerings
• Exhibits143: Cardinal Health Inc. - Segment focus
• Exhibits144: Delphis Pharmaceutical India - Overview
• Exhibits145: Delphis Pharmaceutical India - Product / Service
• Exhibits146: Delphis Pharmaceutical India - Key offerings
• Exhibits147: Eli Lilly and Co. - Overview
• Exhibits148: Eli Lilly and Co. - Product / Service
• Exhibits149: Eli Lilly and Co. - Key offerings
• Exhibits150: F. Hoffmann La Roche Ltd. - Overview
• Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits152: F. Hoffmann La Roche Ltd. - Key news
• Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits155: GlaxoSmithKline Plc - Overview
• Exhibits156: GlaxoSmithKline Plc - Business segments
• Exhibits157: GlaxoSmithKline Plc - Key offerings
• Exhibits158: GlaxoSmithKline Plc - Segment focus
• Exhibits159: Hikma Pharmaceuticals Plc - Overview
• Exhibits160: Hikma Pharmaceuticals Plc - Business segments
• Exhibits161: Hikma Pharmaceuticals Plc - Key offerings
• Exhibits162: Hikma Pharmaceuticals Plc - Segment focus
• Exhibits163: Johnson and Johnson - Overview
• Exhibits164: Johnson and Johnson - Business segments
• Exhibits165: Johnson and Johnson - Key news
• Exhibits166: Johnson and Johnson - Key offerings
• Exhibits167: Johnson and Johnson - Segment focus
• Exhibits168: Parvus Therapeutics Inc. - Overview
• Exhibits169: Parvus Therapeutics Inc. - Product / Service
• Exhibits170: Parvus Therapeutics Inc. - Key offerings
• Exhibits171: Sanofi SA - Overview
• Exhibits172: Sanofi SA - Business segments
• Exhibits173: Sanofi SA - Key news
• Exhibits174: Sanofi SA - Key offerings
• Exhibits175: Sanofi SA - Segment focus
• Exhibits176: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits177: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits178: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits179: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits180: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits181: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits182: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits183: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits184: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits185: Inclusions checklist
• Exhibits186: Exclusions checklist
• Exhibits187: Currency conversion rates for US$
• Exhibits188: Research methodology
• Exhibits189: Validation techniques employed for market sizing
• Exhibits190: Information sources
• Exhibits191: List of abbreviations

Technavio has been monitoring the autoimmune drugs market and is forecast to grow by $29314.5 mn during 2022-2027, accelerating at a CAGR of 6.39% during the forecast period. Our report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, targeted therapeutic mechanism of biologics, and introduction of affordable biosimilars.

Technavio's autoimmune drugs market is segmented as below:

By Therapy Area

• Rheumatoid arthritis
• Multiple sclerosis
• Psoriasis
• Inflammatory bowel disease
• Others

By Distribution Channel

• Hospital
• Pharmacy
• Drug store/Retail pharmacy
• Online

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the reduction in cost of autoimmune drugs as one of the prime reasons driving the autoimmune drugs market growth during the next few years. Also, market dominance by TNF-alpha inhibitors and the development and approval of new drugs will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the autoimmune drugs market covers the following areas:

• Autoimmune drugs market sizing
• Autoimmune drugs market forecast
• Autoimmune drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune drugs market vendors that include AbbVie Inc., AdvaCare Pharma, Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Cardinal Health Inc., Delphis Pharmaceutical India, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson, Medexus Pharmaceuticals Inc., Parvus Therapeutics Inc., Prometheus Laboratories Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Wellona Pharma. Also, the autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global autoimmune drugs market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global autoimmune drugs market 2017 - 2021 ($ million)
• 4.2 Therapy area Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
• 4.3 Distribution channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapy Area

• 6.1 Market segments
• Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
• 6.2 Comparison by Therapy Area
• Exhibit 32: Chart on Comparison by Therapy Area
• Exhibit 33: Data Table on Comparison by Therapy Area
• 6.3 Rheumatoid arthritis - Market size and forecast 2022-2027
• Exhibit 34: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
• 6.4 Multiple sclerosis - Market size and forecast 2022-2027
• Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
• 6.5 Psoriasis - Market size and forecast 2022-2027
• Exhibit 42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
• 6.6 Inflammatory bowel disease - Market size and forecast 2022-2027
• Exhibit 46: Chart on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Inflammatory bowel disease - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Inflammatory bowel disease - Year-over-year growth 2022-2027 (%)
• 6.7 Others - Market size and forecast 2022-2027
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.8 Market opportunity by Therapy Area
• Exhibit 54: Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 57: Chart on Comparison by Distribution Channel
• Exhibit 58: Data Table on Comparison by Distribution Channel
• 7.3 Hospital - Market size and forecast 2022-2027
• Exhibit 59: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Hospital - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
• 7.4 Pharmacy - Market size and forecast 2022-2027
• Exhibit 63: Chart on Pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Pharmacy - Year-over-year growth 2022-2027 (%)
• 7.5 Drug store/Retail pharmacy - Market size and forecast 2022-2027
• Exhibit 67: Chart on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Drug store/Retail pharmacy - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Drug store/Retail pharmacy - Year-over-year growth 2022-2027 (%)
• 7.6 Online - Market size and forecast 2022-2027
• Exhibit 71: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Online - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by Distribution Channel
• Exhibit 75: Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 77: Chart on Market share by geography 2022-2027 (%)
• Exhibit 78: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 79: Chart on Geographic comparison
• Exhibit 80: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 81: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 97: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 101: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 Canada - Market size and forecast 2022-2027
• Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 109: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 110: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 111: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 112: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 113: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 114: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 115: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 116: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 117: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 118: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 119: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 120: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 121: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 122: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 123: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 124: AbbVie Inc. - Overview
• Exhibit 125: AbbVie Inc. - Product / Service
• Exhibit 126: AbbVie Inc. - Key news
• Exhibit 127: AbbVie Inc. - Key offerings
• 12.4 Amgen Inc.
• Exhibit 128: Amgen Inc. - Overview
• Exhibit 129: Amgen Inc. - Product / Service
• Exhibit 130: Amgen Inc. - Key offerings
• 12.5 AstraZeneca Plc
• Exhibit 131: AstraZeneca Plc - Overview
• Exhibit 132: AstraZeneca Plc - Product / Service
• Exhibit 133: AstraZeneca Plc - Key news
• Exhibit 134: AstraZeneca Plc - Key offerings
• 12.6 Bristol Myers Squibb Co.
• Exhibit 135: Bristol Myers Squibb Co. - Overview
• Exhibit 136: Bristol Myers Squibb Co. - Product / Service
• Exhibit 137: Bristol Myers Squibb Co. - Key news
• Exhibit 138: Bristol Myers Squibb Co. - Key offerings
• 12.7 Cardinal Health Inc.
• Exhibit 139: Cardinal Health Inc. - Overview
• Exhibit 140: Cardinal Health Inc. - Business segments
• Exhibit 141: Cardinal Health Inc. - Key news
• Exhibit 142: Cardinal Health Inc. - Key offerings
• Exhibit 143: Cardinal Health Inc. - Segment focus
• 12.8 Delphis Pharmaceutical India
• Exhibit 144: Delphis Pharmaceutical India - Overview
• Exhibit 145: Delphis Pharmaceutical India - Product / Service
• Exhibit 146: Delphis Pharmaceutical India - Key offerings
• 12.9 Eli Lilly and Co.
• Exhibit 147: Eli Lilly and Co. - Overview
• Exhibit 148: Eli Lilly and Co. - Product / Service
• Exhibit 149: Eli Lilly and Co. - Key offerings
• 12.10 F. Hoffmann La Roche Ltd.
• Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 GlaxoSmithKline Plc
• Exhibit 155: GlaxoSmithKline Plc - Overview
• Exhibit 156: GlaxoSmithKline Plc - Business segments
• Exhibit 157: GlaxoSmithKline Plc - Key offerings
• Exhibit 158: GlaxoSmithKline Plc - Segment focus
• 12.12 Hikma Pharmaceuticals Plc
• Exhibit 159: Hikma Pharmaceuticals Plc - Overview
• Exhibit 160: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 161: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 162: Hikma Pharmaceuticals Plc - Segment focus
• 12.13 Johnson and Johnson
• Exhibit 163: Johnson and Johnson - Overview
• Exhibit 164: Johnson and Johnson - Business segments
• Exhibit 165: Johnson and Johnson - Key news
• Exhibit 166: Johnson and Johnson - Key offerings
• Exhibit 167: Johnson and Johnson - Segment focus
• 12.14 Parvus Therapeutics Inc.
• Exhibit 168: Parvus Therapeutics Inc. - Overview
• Exhibit 169: Parvus Therapeutics Inc. - Product / Service
• Exhibit 170: Parvus Therapeutics Inc. - Key offerings
• 12.15 Sanofi SA
• Exhibit 171: Sanofi SA - Overview
• Exhibit 172: Sanofi SA - Business segments
• Exhibit 173: Sanofi SA - Key news
• Exhibit 174: Sanofi SA - Key offerings
• Exhibit 175: Sanofi SA - Segment focus
• 12.16 Takeda Pharmaceutical Co. Ltd.
• Exhibit 176: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 177: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 178: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 179: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.17 Teva Pharmaceutical Industries Ltd.
• Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 185: Inclusions checklist
• Exhibit 186: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 187: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 188: Research methodology
• Exhibit 189: Validation techniques employed for market sizing
• Exhibit 190: Information sources
• 13.5 List of abbreviations
• Exhibit 191: List of abbreviations